Advanz Pharma Corp. buy melinda
Start price
15.08.17
/
50%
€346.37
Target price
19.12.17
€405.90
Performance (%)
-45.31%
End price
19.12.17
€189.42
Summary
This prediction ended on 19.12.17 with a price of €189.42. Massive losses of -45.31% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Advanz Pharma Corp. | - | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by melinda for this prediction
In the thread Advanz Pharma Corp diskutieren
zu folgen
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Advanz Pharma Corp.
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€384.00
15.08.17
15.08.17
€450.00
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€2,570.4
12.08.16
12.08.16
€3,264.0
13.02.17
13.02.17
-74.52%
13.02.17
13.02.17